|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 223/16 | (2006.01) |
| C07D 223/16 | (2013.01) | ||
| C07D 223/32 | (2006.01) | ||
| C07D 223/32 | (2013.01) | ||
| C07D 491/052 | (2006.01) | ||
| C07D 491/052 | (2013.01) | ||
| A61K 31/55 | (2006.01) | ||
| A61P 25/32 | (2018.01) | ||
| A61P 3/04 | (2006.01) | ||
| A61P 3/04 | (2018.01) | ||
| A61P 3/10 | (2018.01) | ||
| A61P 25/08 | (2018.01) | ||
| A61K 31/55 | (2013.01) |
| (11) | Number of the document | 3328835 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16751083.3 |
| Date of filing the European patent application | 2016-07-28 | |
| (97) | Date of publication of the European application | 2018-06-06 |
| (45) | Date of publication and mention of the grant of the patent | 2022-10-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/044426 |
| Date | 2016-07-28 |
| (87) | Number | WO 2017/023679 |
| Date | 2017-02-09 |
| (30) | Number | Date | Country code |
| 201562199382 P | 2015-07-31 | US |
| (72) |
LEHMANN, Juerg , US
FEICHTINGER, Konrad , US
REN, Albert S. , US
SEMPLE, Graeme , US
|
| (73) |
Arena Pharmaceuticals, Inc. ,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | 5-HT2C RECEPTOR AGONISTS AND COMPOSITIONS AND METHODS OF USE |
| 5-HT2C RECEPTOR AGONISTS AND COMPOSITIONS AND METHODS OF USE |